Soiken Holdings (TSE:2385) Current Deferred Revenue: 円0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2385 Soiken Holdings Inc TSE:2385
58 GF Score
Price 円223.00
GF Value 円118.78
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Soiken Holdings Current Deferred Revenue?

Soiken Holdings TSE:2385 +2.29% 58 Current Deferred Revenue is 円0 Mil as of Dec. 2025. GuruFocus rates TSE:2385 with a GF Score™ of 58/100 and a GF Value™ of 円118.78 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Soiken Holdings's current deferred revenue for the quarter that ended in Dec. 2025 was 円0 Mil.

Soiken Holdings Current Deferred Revenue Related Terms

Soiken Holdings Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Soiken Holdings's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Soiken Holdings Current Deferred Revenue Chart

Soiken Holdings Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Soiken Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:2385
58GF Score
Soiken Holdings Inc TSE:2385
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of 円0 Mil mean?
Soiken Holdings (TSE:2385) has a Current Deferred Revenue of 円0 Mil as of Dec. 2025. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Soiken Holdings and its competitors.
Is Soiken Holdings' Current Deferred Revenue too high?
Soiken Holdings' current Current Deferred Revenue is 円0 Mil. Overall, Soiken Holdings has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Soiken Holdings' Current Deferred Revenue compare to VRTX and REGN?
Soiken Holdings' Current Deferred Revenue of 円0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Biotechnology company?
A good Current Deferred Revenue depends on the Biotechnology industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Soiken Holdings and its competitors. Soiken Holdings's current Current Deferred Revenue is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Soiken Holdings stock overvalued right now?
Based on GuruFocus' analysis, Soiken Holdings (TSE:2385) is currently considered Significantly Overvalued. The stock's GF Value™ is 円118.78, compared to a current price of 円223.00 — trading 87.7% above its estimated fair value. The current Current Deferred Revenue is 円0 Mil. Soiken Holdings' overall GF Score™ is 58/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Soiken Holdings (TSE:2385), the current Current Deferred Revenue is 円0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Soiken Holdings (TSE:2385) Overvalued in 2026?

Based on GuruFocus' analysis, Soiken Holdings stock appears to be overvalued. The current stock price of 円223.00 is trading 87.7% above its estimated GF Value™ of 円118.78. GuruFocus considers Soiken Holdings to be Significantly Overvalued.

Key valuation signals for TSE:2385:

  • Current Deferred Revenue: 円0 Mil
  • GF Value™: 円118.78 vs. price of 円223.00 (87.7% above fair value)
  • GF Score™: 58/100 with 1 warning sign

No single metric tells the full story. See the TSE:2385 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Soiken Holdings Business Description

Address 1-4-2 Shinsenri-Higashimachi, 13th Floor, Senri Life Science Center, Toyonaka, Osaka, JPN, 560-0082
Soiken Holdings Inc operates as a biotechnology company in Japan. It provides clinical testing for pharmaceutical and food manufacturers that develop drugs and health food products based on biomarkers. It is involved in the marketing research and post-marketing surveillance of health supplements.
58GF Score

Get the complete analysis for TSE:2385

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円223.00
Price
円118.78
GF Value